Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management

Angela E Lin1, Craig T Basson, Elizabeth Goldmuntz

  • 1Genetics Unit, Department of Pediatrics, MassGeneral Hospital for Children, Boston, Massachusetts 02114, USA. Lin.angela@mgh.harvard.edu

Insights

Genetic syndromes frequently cause congenital heart defects, requiring specialized care for affected adults. This review covers genetic, cardiac, and management issues for common syndromes, including updated data on 22q11.2 deletion and Down syndrome.

Area of Science:

  • Medical Genetics
  • Pediatric Cardiology
  • Clinical Genetics

Background:

  • Congenital heart defects (CHDs) are prevalent in malformation syndromes and genetic disorders.
  • Syndromic individuals represent a significant portion of patients with specific CHDs like atrioventricular canal and pulmonary stenosis.
  • An aging population with special healthcare needs necessitates awareness of cardiovascular issues in genetic syndromes.

Purpose of the Study:

  • To review genetic, cardiac, medical, and reproductive aspects of common genetic syndromes associated with cardiovascular abnormalities.
  • To provide updated information on the cardiac status of adults with 22q11.2 deletion and Down syndrome.
  • To inform primary care providers, geneticists, and specialists on managing cardiovascular complications in these patients.

Main Methods:

  • Literature review of genetic syndromes and associated cardiovascular abnormalities.
  • Synthesis of current knowledge on clinical outcomes and management guidelines.
  • Inclusion of new data on adult cardiac status in 22q11.2 deletion and Down syndrome.

Main Results:

  • Specific CHDs are disproportionately represented in individuals with genetic syndromes.
  • Adults with genetic syndromes require long-term cardiology follow-up.
  • Updated data highlight the cardiac status in adults with 22q11.2 deletion and Down syndrome.

Conclusions:

  • Healthcare providers must be knowledgeable about cardiovascular risks in genetic syndromes.
  • Comprehensive management strategies are crucial for addressing the spectrum of cardiac issues.
  • Understanding genetic, cardiac, and reproductive factors is essential for optimal patient care.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...